IP strategy

White paper

IP strategy

Companies face different situations today when moving into a strategic approach to IP management. This white paper aims to summarize these situations and reflects the views of ~400 IP and innovation professionals working in IP and innovation (R&D, R&I or the like) departments in a wide range of companies (large and SMEs), patent law firms and other organizations. The document is a compilation of both positive and less positive experiences, i.a. on the design, the implementation and the execution of the IP plan.


Download now the white paper 'IP strategy'.

Editor: Patentopolis B.V. 


 

Download now


White paper

IP strategy

Download

Free Download

Once you have completed the following fields, you can download the desired content. Alternatively, log in to your customer portal. The document will then be freely available to you.
I agree that the FORUM Institut may contact me to inform me about events and relevant content.
I can revoke my permission at any time.
5 + 3 =   


        

Events “

Do filter
Sort
Tiles
Lists
Global Regulatory Affairs Manager

This online seminar provides a comprehensive overview of global regulatory affairs, covering strategies for setting regulatory policies, developing global regulatory dossiers, understanding HTA interfaces, enhancing global communication, and staying updated on ICH guidelines, ISO IDMP updates, and global regulatory trends.

10-11/03/2025
All about ATMP

The online seminar with details on development, quality, CMC, approval and market access (including an update on the upcoming EU HTA) for advanced therapy medicinal products. Qualifiy now!

12-13/03/2025
IP Agreements: Research and Development Agreements

Participants, doing business in a complex multi-jurisdictional environment, will be enabled to address difficult situations when designing and negotiating R&D agreements in cross-border projects.

17/03/2025
IP Agreements: Patent License Agreements

Participants, doing business in a complex multi-jurisdictional environment, will be enabled to address difficult situations when designing and negotiating patent license agreements in cross-border projects.

18/03/2025
Global Pharmacovigilance Inspection Readiness

- Register by 9 March 2025 - Learn how to prepare your pharmacovigilance system in Germany, Europe and worldwide for an upcoming inspection in this one-day online course. Gain a comprehensive understanding of the EMA's Good Pharmacovigilance Practice (GVP/GPvP) modules, strategic and remote planning and preparation, and differences in GVP inspections around the world.

24/03/2025
Pharmaceutical industry in transition: The importance of AI for quality & efficiency

Pharmaceutical industry in transition: The importance of AI for quality & efficiency - Artificial Intelligenge in GxP-/ISO-regulated areas.

27/03/2025
IP Risk Management

This online course is about techniques and tools for IP risk mitigation. Attendees will learn how to set up a proper IP risk management process.

01/04/2025
Patent Drafting with local Generative AI

Join our one-day course and discover how to boost patent drafting with the local generative AI. This immersive workshop offers patent attorneys, counsels, and engineers a unique opportunity to gain hands-on experience with local generative AI with ensured data confidentiality.

01/04/2025
US & EU Licensing: A Hands-On Course on The Law And Best Practices

This online course provides drafting and negotiating advice for EU practitioners, with precise references to existing US law.

02-03/04/2025
AI Patent Application Drafting

Learn how to write AI patent applications which get granted and are infringed upon! This online course will give you the best practical tips to improve your skills in drafting applications for AI patents. Apply your knowledge in a practical test including feedback from our expert speakers.

03/04/2025
Marketing Authorisation Procedures in the EU

This seminar provides an in-depth exploration of EU drug marketing authorisation, focusing on regulatory frameworks, application types and procedures. It covers mutual recognition, decentralised and centralised procedures (MRP, DCP, CP) in detail, providing essential insights for successful EU drug approval.

09/04/2025